Atom-Dimer Scattering in a Three-Component Fermi Gas

Ultracold gases of three distinguishable particles with large scattering lengths are expected to show rich few-body physics related to the Efimov effect. We have created three different mixtures of ultracold 6Li atoms and weakly bound 6Li2 dimers consisting of atoms in three different hyperfine states and studied their inelastic decay via atom-dimer collisions. We have found resonant enhancement of the decay due to the crossing of Efimov-like trimer states with the atom-dimer continuum in one mixture as well as minima of the decay in another mixture, which we interpret as a suppression of exchange reactions of the type |12>+|3> -> |23>+|1>. Such a suppression is caused by interference between different decay paths and demonstrates the possiblity to use Efimov physics to control the rate constants for molecular exchange reactions in the ultracold regime.Comment: 5 pages, 3 figure

Fermionization of two distinguishable fermions

In this work we study a system of two distinguishable fermions in a 1D harmonic potential. This system has the exceptional property that there is an analytic solution for arbitrary values of the interparticle interaction. We tune the interaction strength via a magnetic offset field and compare the measured properties of the system to the theoretical prediction. At the point where the interaction strength diverges, the energy and square of the wave function for two distinguishable particles are the same as for a system of two identical fermions. This is referred to as fermionization. We have observed this phenomenon by directly comparing two distinguishable fermions with diverging interaction strength with two identical fermions in the same potential. We observe good agreement between experiment and theory. By adding one or more particles our system can be used as a quantum simulator for more complex few-body systems where no theoretical solution is available

Observation of an Efimov resonance in an ultracold mixture of atoms and weakly bound dimers

We discuss our recent observation of an atom-dimer Efimov resonance in an ultracold mixture of Cs atoms and Cs_2 Feshbach molecules [Nature Phys. 5, 227 (2009)]. We review our experimental procedure and present additional data involving a non-universal g-wave dimer state, to contrast our previous results on the universal s-wave dimer. We resolve a seeming discrepancy when quantitatively comparing our experimental findings with theoretical results from effective field theory.Comment: Conference Proceeding ICPEAC 2009 Kalamazoo, to appear in Journal of Physics: Conference Serie

Observation of an Efimov resonance in an ultracold mixture of atoms and weakly bound dimers

We discuss our recent observation of an atom-dimer Efimov resonance in an ultracold mixture of Cs atoms and Cs_2 Feshbach molecules [Nature Phys. 5, 227 (2009)]. We review our experimental procedure and present additional data involving a non-universal g-wave dimer state, to contrast our previous results on the universal s-wave dimer. We resolve a seeming discrepancy when quantitatively comparing our experimental findings with theoretical results from effective field theory.Comment: Conference Proceeding ICPEAC 2009 Kalamazoo, to appear in Journal of Physics: Conference Serie

Observation of an Efimov resonance in an ultracold mixture of atoms and weakly bound dimers

We discuss our recent observation of an atom-dimer Efimov resonance in an ultracold mixture of Cs atoms and Cs_2 Feshbach molecules [Nature Phys. 5, 227 (2009)]. We review our experimental procedure and present additional data involving a non-universal g-wave dimer state, to contrast our previous results on the universal s-wave dimer. We resolve a seeming discrepancy when quantitatively comparing our experimental findings with theoretical results from effective field theory.Comment: Conference Proceeding ICPEAC 2009 Kalamazoo, to appear in Journal of Physics: Conference Serie

Efimov Trimers near the Zero-crossing of a Feshbach Resonance

Near a Feshbach resonance, the two-body scattering length can assume any value. When it approaches zero, the next-order term given by the effective range is known to diverge. We consider the question of whether this divergence (and the vanishing of the scattering length) is accompanied by an anomalous solution of the three-boson Schr\"odinger equation similar to the one found at infinite scattering length by Efimov. Within a simple zero-range model, we find no such solutions, and conclude that higher-order terms do not support Efimov physics.Comment: 8 pages, no figures, final versio

Efimov physics from the functional renormalization group

Few-body physics related to the Efimov effect is discussed using the functional renormalization group method. After a short review of renormalization in its modern formulation we apply this formalism to the description of scattering and bound states in few-body systems of identical bosons and distinguishable fermions with two and three components. The Efimov effect leads to a limit cycle in the renormalization group flow. Recently measured three-body loss rates in an ultracold Fermi gas $^6$Li atoms are explained within this framework. We also discuss briefly the relation to the many-body physics of the BCS-BEC crossover for two-component fermions and the formation of a trion phase for the case of three species.Comment: 28 pages, 13 figures, invited contribution to a special issue of "Few-Body Systems" devoted to Efimov physics, published versio

Advanced Technologies for Oral Controlled Release: Cyclodextrins for oral controlled release

Cyclodextrins (CDs) are used in oral pharmaceutical formulations, by means of inclusion complexes formation, with the following advantages for the drugs: (1) solubility, dissolution rate, stability and bioavailability enhancement; (2) to modify the drug release site and/or time profile; and (3) to reduce or prevent gastrointestinal side effects and unpleasant smell or taste, to prevent drug-drug or drug-additive interactions, or even to convert oil and liquid drugs into microcrystalline or amorphous powders. A more recent trend focuses on the use of CDs as nanocarriers, a strategy that aims to design versatile delivery systems that can encapsulate drugs with better physicochemical properties for oral delivery. Thus, the aim of this work was to review the applications of the CDs and their hydrophilic derivatives on the solubility enhancement of poorly water soluble drugs in order to increase their dissolution rate and get immediate release, as well as their ability to control (to prolong or to delay) the release of drugs from solid dosage forms, either as complexes with the hydrophilic (e.g. as osmotic pumps) and/ or hydrophobic CDs. New controlled delivery systems based on nanotechonology carriers (nanoparticles and conjugates) have also been reviewed

Efimov physics beyond universality

We provide an exact solution of the Efimov spectrum in ultracold gases within the standard two-channel model for Feshbach resonances. It is shown that the finite range in the Feshbach coupling makes the introduction of an adjustable three-body parameter obsolete. The solution explains the empirical relation between the scattering length a_- where the first Efimov state appears at the atom threshold and the van der Waals length l_vdw for open channel dominated resonances. There is a continuous crossover to the closed channel dominated limit, where the scale in the energy level diagram as a function of the inverse scattering length 1/a is set by the intrinsic length r* associated with the Feshbach coupling. Our results provide a number of predictions for non-universal ratios between energies and scattering lengths that can be tested in future experiments.Comment: 6 pages, 4 figures; final versio

PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia

BACKGROUND: Cells from individuals with Friedreich's ataxia (FRDA) show reduced activities of antioxidant enzymes and cannot up-regulate their expression when exposed to oxidative stress. This blunted antioxidant response may play a central role in the pathogenesis. We previously reported that Peroxisome Proliferator Activated Receptor Gamma (PPARgamma) Coactivator 1-alpha (PGC-1alpha), a transcriptional master regulator of mitochondrial biogenesis and antioxidant responses, is down-regulated in most cell types from FRDA patients and animal models. METHODOLOGY/PRINCIPAL FINDINGS: We used primary fibroblasts from FRDA patients and the knock in-knock out animal model for the disease (KIKO mouse) to determine basal superoxide dismutase 2 (SOD2) levels and the response to oxidative stress induced by the addition of hydrogen peroxide. We measured the same parameters after pharmacological stimulation of PGC-1alpha. Compared to control cells, PGC-1alpha and SOD2 levels were decreased in FRDA cells and did not change after addition of hydrogen peroxide. PGC-1alpha direct silencing with siRNA in control fibroblasts led to a similar loss of SOD2 response to oxidative stress as observed in FRDA fibroblasts. PGC-1alpha activation with the PPARgamma agonist (Pioglitazone) or with a cAMP-dependent protein kinase (AMPK) agonist (AICAR) restored normal SOD2 induction. Treatment of the KIKO mice with Pioglitazone significantly up-regulates SOD2 in cerebellum and spinal cord. CONCLUSIONS/SIGNIFICANCE: PGC-1alpha down-regulation is likely to contribute to the blunted antioxidant response observed in cells from FRDA patients. This response can be restored by AMPK and PPARgamma agonists, suggesting a potential therapeutic approach for FRDA.Journal ArticleResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publishe